Fewer Patients with PTSD Survive COVID
Risk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.
University of California San Francisco
Give to UCSFRisk of death or hospitalization from COVID-19 were found to be greater for patients with PTSD.
Researchers have identified specific immune cells that drive deadly heart inflammation in a small fraction of patients treated with powerful cancer immunotherapy drugs.
A new method of comparing massive numbers of CAR-T cells can determine which is most effective and long-lasting against cancer.
UCSF Benioff Children’s Hospitals experts weigh in on what RSV is and why we’re seeing so many cases.
Immune checkpoint inhibitors (ICIs) used in cancer care can cause myocarditis, a potentially fatal side effect, and it appears that the adverse cardiac effects may disproportionally impact female patients.
Nevan Krogan, PhD, director of UC San Francisco’s (UCSF) Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
Nevan Krogan, PhD, director UCSF’s Quantitative Biosciences Institute (QBI) and founder of QBI’s Coronavirus Research Group (QCRG), has been awarded the Legion of Honor, France’s highest honor, in a ceremony in Paris.
A new diagnostic method that applies machine learning to advanced genomics data from both microbe and host to identify and predict sepsis cases was developed by researchers at UCSF, the Chan Zuckerberg Initiative, and CZ Biohub.
Scientists at UCSF have developed a new way of looking at sex-biased diseases that is rooted in evolutionary biology.
A new study points to another persistent effect of COVID-19, identified months after infection: reduced exercise capacity.
Last month new “bivalent” booster vaccines made by Moderna and Pfizer became available that protect against currently circulating Omicron variants as well as earlier strains of the SARS-CoV-2 virus that causes COVID-19. This Q&A features Joel Ernst, MD, a UCSF professor of medicine whose research aims to understand how pathogens evade the immune system.
A mortality prediction model for older adults with dementia may help physicians determine which treatments to provide while facilitating decision-making for patients and their families.
On a sunny Friday, teams of aspiring young scientists gathered in the Clinical Sciences building at Parnassus Heights to look for treasure in a trillion data points about cancer.
Using equations to calculate kidney function that do not include race adjustments would result in Black patients gaining time before their kidneys fail.
A new therapy pulls forward a mutated version of the KRAS protein to help the immune system recognize and destroy cancer cells.
UCSF-led research outlines the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. Their findings could reveal the mechanism of neoplastic progression and provide targets for immunotherapy to inhibit progression or treat invasive disease.
A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC San Francisco (UCSF), lets scientists introduce especially long DNA sequences to precise locations in the genomes of cells at remarkably high efficiencies without the viral delivery systems that have traditionally been used to carry DNA into cells.